Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T23:27:56.291Z Has data issue: false hasContentIssue false

Evaluation of the impact of nasal colonization with methicillin-resistant Staphylococcus aureus on left ventricular assist device infections

Published online by Cambridge University Press:  10 May 2022

Lauren J. Koscal*
Affiliation:
Department of Pharmacy, University of Florida Health at Jacksonville, Jacksonville, Florida
Holly Meadows
Affiliation:
Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina
Brian R. Raux
Affiliation:
Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina
Krutika N. Mediwala
Affiliation:
Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina
Erin Weeda
Affiliation:
Medical University of South Carolina, College of Pharmacy, Charleston, South Carolina
Brian Houston
Affiliation:
Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina
Deeksha Jandhyala
Affiliation:
Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina
Jaclyn M. Hawn
Affiliation:
Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina
*
Author for correspondence: Lauren Koscal, PharmD, BCPS, University of Florida Health, 15255 Max Leggett Pkwy, Jacksonville, FL 32218. E-mail:lauren.koscal@jax.ufl.edu

Abstract

In this retrospective cohort study, we evaluated the predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swabs for the development of MRSA infections in patients with left ventricular assist devices. In 106 patients, the MRSA nasal swab had a negative predictive value of 92.9% demonstrating a potential role in antibiotic de-escalation.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Baseline Characteristics

Figure 1

Table 2.Secondary Outcomes